FDA Targets High Throughput COVID-19 Tests for Recall Due to Risks of False Positives by Glenn S. Demby | Oct 19, 2021 | Articles, Diagnostic Testing and Emerging Technologies, FDA-nir...This content is for Paid Members only.Login Register